Clinical Trial Update: Effect of EPA and DHA in the Inflammation and Metabolic Disorders in DMD/DMB Patients [NA]

View source ↗

Summary

A completed clinical trial evaluated the effects of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) on inflammation and metabolic parameters in Duche…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duchenne Muscular Dystrophy

Drugs mentioned

• Docosahexaenoic acid (DHA) (docosahexaenoic acid)
• Eicosapentaenoic acid (EPA) (eicosapentaenoic acid)

Snippet

Sponsor: Coordinación de Investigación en Salud, Mexico | Conditions: Muscular Dystrophy, Duchenne | NA | Status: COMPLETED | Results posted: 2018-02-01